top
Search terms
Results 1 - 10 of 10 - ordered by :
Ejhf

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial Research ...

European Journal of Heart Failure, Kristensen, Søren L., Mogensen, Ulrik M., Tarnesby, Georgia, Gimpelewicz, Claudio R., Ali, Mohammed A., Shao, Qing, Chiang, YannTong, Jhund, Pardeep S., Abraham, ...

Date : 01/01/2018 Item size : 167130 bytes
Ehjournal

Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from ...

European Heart Journal, Böhm, Michael, Young, Robin, Jhund, Pardeep S., Solomon, Scott D., Gong, Jianjian, Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Swedberg, Karl, ...

Date : 14/04/2017 Item size : 379104 bytes
Ejhf

[1] However, as we have described elsewhere, the premature termination of the Aliskiren Trial In Type 2 Diabetes Using Cardio-Renal Disease Endpoints (ALTITUDE) because of futility and safety ...

European Journal of Heart Failure, Krum, Henry, McMurray, John J.V., Abraham, William T., Dickstein, Kenneth, Køber, Lars, Desai, Akshay S., Solomon, Scott D., Chiang, Yanntong, Gimpelewicz, ...

Date : 01/10/2015 Item size : 161211 bytes
Ejhf

[1] However, as we have described elsewhere, the premature termination of the Aliskiren Trial In Type 2 Diabetes Using Cardio-Renal Disease Endpoints (ALTITUDE) because of futility and safety ...

European Journal of Heart Failure, Krum, Henry, McMurray, John J.V., Abraham, William T., Dickstein, Kenneth, Køber, Lars, Desai, Akshay S., Solomon, Scott D., Chiang, Yanntong, Gimpelewicz, ...

Date : 01/10/2015 Item size : 164085 bytes
Ehjournal

Introduction Oral anticoagulation is recommended for the prevention of thromboembolic events in patients with atrial fibrillation (AF) at risk for stroke.13 Oral anticoagulants have been shown to be ...

European Heart Journal, Alexander, John H., Lopes, Renato D., Thomas, Laine, Alings, Marco, Atar, Dan, Aylward, Philip, Goto, Shinya, Hanna, Michael, Huber, Kurt, Husted, Steen, Lewis, Basil S., ...

Date : 21/01/2014 Item size : 298281 bytes
Ehjournal

Introduction Oral anticoagulation is recommended for the prevention of thromboembolic events in patients with atrial fibrillation (AF) at risk for stroke.13 Oral anticoagulants have been shown to be ...

European Heart Journal, Alexander, John H., Lopes, Renato D., Thomas, Laine, Alings, Marco, Atar, Dan, Aylward, Philip, Goto, Shinya, Hanna, Michael, Huber, Kurt, Husted, Steen, Lewis, Basil S., ...

Date : 21/01/2014
Ejhf

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of ...

European Journal of Heart Failure, Chang, Su Min, Granger, Christopher B., Johansson, Peter A., Kosolcharoen, Peter, McMurray, John J.V., Michelson, Eric L., Murray, David R., Olofsson, Bertil, ...

Date : 01/07/2010 Item size : 163589 bytes
Ejhf

Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of ...

European Journal of Heart Failure, Chang, Su Min, Granger, Christopher B., Johansson, Peter A., Kosolcharoen, Peter, McMurray, John J.V., Michelson, Eric L., Murray, David R., Olofsson, Bertil, ...

Date : 01/07/2010 Item size : 164755 bytes
Ejhf

Introduction Poor adherence to medication in patients with chronic heart failure (CHF) limits the effectiveness of proven treatments.1 As shown in recent reports, the majority of patients are not ...

European Journal of Heart Failure, Granger, Bradi B., Ekman, Inger, Granger, Christopher B., Ostergren, Jan, Olofsson, Bertil, Michelson, Eric, McMurray, John J.V., Yusuf, Salim, Pfeffer, Marc A., ...

Date : 01/11/2009 Item size : 177617 bytes
Ejhf

Introduction Poor adherence to medication in patients with chronic heart failure (CHF) limits the effectiveness of proven treatments.1 As shown in recent reports, the majority of patients are not ...

European Journal of Heart Failure, Granger, Bradi B., Ekman, Inger, Granger, Christopher B., Ostergren, Jan, Olofsson, Bertil, Michelson, Eric, McMurray, John J.V., Yusuf, Salim, Pfeffer, Marc A., ...

Date : 01/11/2009 Item size : 179655 bytes